Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Trial
- Publication date
- 1 April 2015
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'